PYPD Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 9 analysts giving stock ratings to PolyPid Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
22
Buy
67
Hold
11
Sell
0
Strong Sell
0
PolyPid Ltd

PolyPid Ltd. Stock Analysis PYPD

United States Health Care Nano Cap
PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Read More

PYPD Chart

United States Health Care Nano Cap

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.78$2.85

Today's Open

$2.85

Volume

14.60K

P/E Ratio (TTM)

-

52 Week Range

$2.30$5.09

Market Cap

29.04M

Avg. Volume

30.32K

Dividend Yield

-

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.